Naomi Williams
Family · Universal City, TXNPI 1144008491
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,836 of the $4,401 with a category attached, or 87.2%. It is spread thinly across 37 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,140 and has fallen 92.6% since, to $234 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 138 payments — averaging $31.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$452
- Daiichi Sankyo Inc.$400
- AstraZeneca$314
- Lilly USA, LLC$288
- Merck$282
- Genentech USA, Inc.$274
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,83687%
- Education$56413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 6 | $452 |
| Daiichi Sankyo Inc. | 10 | $400 |
| AstraZeneca(2 entities) | 14 | $314 |
| Lilly USA, LLC | 7 | $288 |
| Merck | 13 | $282 |
| Genentech USA, Inc. | 5 | $274 |
| Regeneron Healthcare Solutions, Inc. | 3 | $273 |
| Johnson & Johnson | 3 | $246 |
| Eisai Inc. | 8 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $165 |
| Novartis | 7 | $150 |
| Bayer | 5 | $125 |
| Tempus AI, Inc | 1 | $114 |
| E.r. Squibb & Sons, L.L.C. | 1 | $112 |
| Incyte Corporation | 5 | $109 |
| Ipsen Biopharmaceuticals, Inc | 5 | $99 |
| AbbVie | 4 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Immunocore Limited | 2 | $57 |
| Karyopharm Therapeutics Inc. | 3 | $57 |
| Deciphera Pharmaceuticals Inc. | 2 | $55 |
| Morphosys, US Inc. | 2 | $49 |
| Pfizer | 2 | $49 |
| Sanofi | 2 | $45 |
| Spectrum Pharmaceuticals Inc. | 2 | $43 |
| Stemline Therapeutics Inc. | 2 | $42 |
| EMD Serono, Inc. | 2 | $38 |
| Servier Pharmaceuticals LLC | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $32 |
| Taiho Oncology, Inc. | 1 | $29 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $24 |
| Sobi, Inc | 1 | $23 |
| Recordati_rare_diseases_inc. | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Exelixis Inc. | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,401 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 15 | $606 |
| Ondansetron OdtOndansetron | 15 | $378 |
| Triamcinolone Acetonide | 14 | $213 |
| Duloxetine Hcl | 11 | $163 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $128 |
Paid to pharmacies, not to this prescriber.
Other family in Universal City
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.